lomefloxacin has been researched along with Escherichia coli Infections in 6 studies
lomefloxacin: structure given in first source
lomefloxacin : A fluoroquinolone antibiotic, used (generally as the hydrochloride salt) to treat bacterial infections including bronchitis and urinary tract infections. It is also used to prevent urinary tract infections prior to surgery.
Escherichia coli Infections: Infections with bacteria of the species ESCHERICHIA COLI.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The efficacy and safety of two fluoroquinolone antimicrobial agents, lomefloxacin and ciprofloxacin, were compared in a randomized, investigator-blinded, multiple-dose study that enrolled 150 adult outpatients with complicated or recurrent urinary tract infections." | 9.07 | A comparison of the safety and efficacy of lomefloxacin and ciprofloxacin in the treatment of complicated or recurrent urinary tract infections. ( Cox, CE, 1992) |
| "A total of 63 adult patients with uncomplicated acute pyelonephritis were enrolled in a multicenter, randomized comparison of lomefloxacin (400 mg orally once daily for 14 days) and trimethoprim/sulfamethoxazole (TMP/SMX, 160/800 mg orally twice daily for 14 days)." | 9.07 | A multicenter study of lomefloxacin and trimethoprim/sulfamethoxazole in the treatment of uncomplicated acute pyelonephritis. ( Ajana, F; Capron, MH; Chidiac, C; Home, P; Masquelier, AM; Mouton, Y, 1992) |
| "Data were collected from 14 French centres which participated in a randomized study to compare the safety and efficacy of 400 mg lomefloxacin taken orally once daily by 62 patients with 160/800 mg trimethoprim/sulphamethoxazole (TMP/SMX) taken orally twice daily by 64 patients with uncomplicated urinary tract infections." | 9.07 | Uncomplicated urinary tract infections: lomefloxacin versus trimethoprim/sulphamethoxazole. ( Capron, MH; Guibert, J, 1992) |
| "The efficacy and safety of two fluoroquinolone antimicrobial agents, lomefloxacin and ciprofloxacin, were compared in a randomized, investigator-blinded, multiple-dose study that enrolled 150 adult outpatients with complicated or recurrent urinary tract infections." | 5.07 | A comparison of the safety and efficacy of lomefloxacin and ciprofloxacin in the treatment of complicated or recurrent urinary tract infections. ( Cox, CE, 1992) |
| "A total of 63 adult patients with uncomplicated acute pyelonephritis were enrolled in a multicenter, randomized comparison of lomefloxacin (400 mg orally once daily for 14 days) and trimethoprim/sulfamethoxazole (TMP/SMX, 160/800 mg orally twice daily for 14 days)." | 5.07 | A multicenter study of lomefloxacin and trimethoprim/sulfamethoxazole in the treatment of uncomplicated acute pyelonephritis. ( Ajana, F; Capron, MH; Chidiac, C; Home, P; Masquelier, AM; Mouton, Y, 1992) |
| "Data were collected from 14 French centres which participated in a randomized study to compare the safety and efficacy of 400 mg lomefloxacin taken orally once daily by 62 patients with 160/800 mg trimethoprim/sulphamethoxazole (TMP/SMX) taken orally twice daily by 64 patients with uncomplicated urinary tract infections." | 5.07 | Uncomplicated urinary tract infections: lomefloxacin versus trimethoprim/sulphamethoxazole. ( Capron, MH; Guibert, J, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamane, K | 1 |
| Wachino, J | 1 |
| Suzuki, S | 1 |
| Kimura, K | 1 |
| Shibata, N | 1 |
| Kato, H | 1 |
| Shibayama, K | 1 |
| Konda, T | 1 |
| Arakawa, Y | 1 |
| Tavío, MM | 1 |
| Vila, J | 1 |
| Ruiz, J | 2 |
| Martín-Sánchez, AM | 1 |
| Jiménez de Anta, MT | 1 |
| Voss, LM | 1 |
| Ellis-Pegler, RB | 1 |
| Cox, CE | 1 |
| Mouton, Y | 1 |
| Ajana, F | 1 |
| Chidiac, C | 1 |
| Capron, MH | 2 |
| Home, P | 1 |
| Masquelier, AM | 1 |
| Guibert, J | 1 |
3 trials available for lomefloxacin and Escherichia coli Infections
| Article | Year |
|---|---|
A comparison of the safety and efficacy of lomefloxacin and ciprofloxacin in the treatment of complicated or recurrent urinary tract infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Escherichia coli Infections; F | 1992 |
A multicenter study of lomefloxacin and trimethoprim/sulfamethoxazole in the treatment of uncomplicated acute pyelonephritis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Escherichia coli I | 1992 |
Uncomplicated urinary tract infections: lomefloxacin versus trimethoprim/sulphamethoxazole.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Drug Admini | 1992 |
3 other studies available for lomefloxacin and Escherichia coli Infections
| Article | Year |
|---|---|
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chitosan; Con | 2007 |
Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates.
Topics: Anti-Infective Agents; Bacterial Outer Membrane Proteins; DNA Topoisomerase IV; DNA Topoisomerases, | 1999 |
Patients with infectious gastroenteritis in New Zealand rarely need antimicrobial treatment.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter Infections; Campylobacter jejuni; Drug R | 2000 |